The Landscape of Neutralizing Monoclonal Antibodies (nAbs) for Treatment and Prevention of COVID-19

PURPOSE: After nearly 3 years of the COVID-19 pandemic, even though a vast body of knowledge and products (including vaccines and treatments) have been developed and disseminated, the virus is still evolving and new variants arising. Consequently, thousands of lives continue to be lost. Neutralizing...

Descripción completa

Detalles Bibliográficos
Autores principales: de Almeida Oliveira, Aline, Praia Borges Freire, Diana, Rodrigues de Andrade, Ana, de Miranda Marques, Amanda, da Silva Madeira, Luciana, Moreno Senna, José Procópio, Freitas Brasileiro da Silveira, Ivna Alana, de Castro Fialho, Beatriz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943047/
https://www.ncbi.nlm.nih.gov/pubmed/36843665
http://dx.doi.org/10.1007/s12247-023-09713-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943047/
https://www.ncbi.nlm.nih.gov/pubmed/36843665
http://dx.doi.org/10.1007/s12247-023-09713-w

Ejemplares similares